The Anti-Tumor Immune Response Induced by a Combination of MAGE-3/MAGE-n-derived Peptides

Oncology Reports - Greece
doi 10.3892/or.20.1.245
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Monoclonal Anti-Mage-3 CTL Responses in Melanoma Patients Displaying Tumor Regression After Vaccination With a Recombinant Canarypox Virus

Journal of Immunology
AllergyImmunology
2003English

MAGE: A Distributed Programming Model

English

Preparation and Antitumor Effects of Nanovaccines With MAGE-3 Peptides in Transplanted Gastric Cancer in Mice

Chinese Journal of Cancer
2010English

Evaluation of MAGE-1 and MAGE-3 as Tumour-Specific Markers to Detect Blood Dissemination of Hepatocellular Carcinoma Cells

British Journal of Cancer
Cancer ResearchOncology
2002English

CRMAGE: CRISPR Optimized MAGE Recombineering

Scientific Reports
Multidisciplinary
2016English

Anti-Tumor Immune Responses Induced by Radiotherapy: A Review

Fukushima Journal of Medical Sciences
Medicine
2015English

Erratum to “Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma”

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

STAT3, a Master Regulator of Anti-Tumor Immune Response

Cancers
Cancer ResearchOncology
2019English

Correlation Between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated With a MAGE Antigen

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy